Microsoft Word - AHA063BF

نویسنده

  • G. Gino Schilirò
چکیده

Gino Schilirò, Antonio Russo, Cattedra di Ematologia Pediatrica, Istituto di Clinica Pediatrica I, Università di Catania, Viale A. Doria 6, I-95125 Catania (Italy) It is now widely accepted that the best treatment for thalassemia major is a precocious and regular transfusional regimen with the aim of maintaining pretransfusional Hb levels of 10.511 g/dl [1]. Such an approach, by minimizing the growth disturbances and serious cardiac complications, has greatly improved the quality of life and survival of thalassemic patients. On the other hand, the hemosiderosis secondary to hypertransfusion regimen is a serious threat for a long life expectancy. This concern and the general assumption that desferrioxamine treatment has minimal side effects resulted in a generalized tendency toward the use of high doses of desferrioxamine. The reduction of serum ferritin below 1,000 μg/ml is considered an objective to pursue with determination [1]. We believe that now it is time for a pause of meditation. In the last few years, together with the increase of desferrioxamine doses, important side effects have been reported frequently. Potentially life-threatening infections from Yersinia enterocolitica have been reported with increasing frequency in thalassemic patients [2]. It has been postulated that the large amount of iron excreted through the intestine as a consequence of the chelation treatment may represent a growth factor for the bacteria. Other alarming side effects, although rare, are cataracts [3], visul-field defects [4] and acute visual loss [5]; however, more subtle signs of visual and auditory neurotoxicity may be discovered with a certain frequency when accurate visual tests, visual evoked potentials and audiometry are performed [6]. The dose of desferrioxamine administered to patients with abnormal tests was significantly higher than in normals [6]. Growth velocity was significantly reduced in 47 of 71 prepubertal thalassemic children undergoing high-dose desferrioxamine treatment [Gabutti, pers. com-mun.]; growth resumed after dose reduction in 16 of 47 children. It has been postulated that disproportionately high doses of desferrioxamine in relation to the amount of body iron result in high levels of unchelated drug, which may be toxic [6]. One of the mechanisms of tox-icity, which has been quoted but not proved, is the chelation of trace elements such as zinc and copper [4, 6]. In our experience patients with good compliance to chelation therapy have low neutrophil zinc content and zinc levels, whereas urinary zinc excretion is significantly higher than in those patients with poor compliance to treatment [7]. Although convincing explanations are still lacking, the importance of complications associated to high-dose desferrioxamine therapy cannot be overlooked. Careful clinical surveillance programs, integrated by the use of neurophysiologic tests, should be undertaken in any center taking care of thalassemic patients in order to assess the true incidence of

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Microsoft Word - AHA063BF

M.L. Randi, F. Fabris, C. Vio, A. Girolami, University of Padua, Institute of Medical Semeiotics, Via Ospedale, 105‚ I-35100 Padua (Italy) Several instances of familial polycythemia vera (PV) have been described [1,6, 9]; however, no data are available on the incidence of primary or secondary thrombocytosis in the same family. Over the last 10 years we have studied 170 subjects with thrombocyto...

متن کامل

Accessible Instruction - Resources

Introduction to Accessible Education [2] Developing Courses [3] Writing a Course Syllabus [4] Creating Accessible Lectures [5] Using PowerPoint [6] Using Word Documents and/or PDFs [7] Microsoft Word Accessibility Video pt 1 [8] Microsoft Word Accessibility Video pt 2 [9] Evaluating Students and Giving Feedback [10] Using Microsoft Office Microsoft Office 2010 Accessibility Video [11] Microsoft...

متن کامل

Accessible Instruction - Resources

Introduction to Accessible Education [2] Developing Courses [3] Writing a Course Syllabus [4] Creating Accessible Lectures [5] Using PowerPoint [6] Using Word Documents and/or PDFs [7] Microsoft Word Accessibility Video pt 1 [8] Microsoft Word Accessibility Video pt 2 [9] Evaluating Students and Giving Feedback [10] Using Microsoft Office Microsoft Office 2010 Accessibility Video [11] Microsoft...

متن کامل

Accessible Instruction - Resources

Introduction to Accessible Education [2] Developing Courses [3] Writing a Course Syllabus [4] Creating Accessible Lectures [5] Using PowerPoint [6] Using Word Documents and/or PDFs [7] Microsoft Word Accessibility Video pt 1 [8] Microsoft Word Accessibility Video pt 2 [9] Evaluating Students and Giving Feedback [10] Using Microsoft Office Microsoft Office 2010 Accessibility Video [11] Microsoft...

متن کامل

Accessible Instruction - Resources

Introduction to Accessible Education [2] Developing Courses [3] Writing a Course Syllabus [4] Creating Accessible Lectures [5] Using PowerPoint [6] Using Word Documents and/or PDFs [7] Microsoft Word Accessibility Video pt 1 [8] Microsoft Word Accessibility Video pt 2 [9] Evaluating Students and Giving Feedback [10] Using Microsoft Office Microsoft Office 2010 Accessibility Video [11] Microsoft...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009